Concord Wealth Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-26
Closed 1414
2022
Q1
$0 Hold
26
﹤0.01% 1419
2021
Q4
$0 Hold
26
﹤0.01% 1360
2021
Q3
$1K Buy
+26
New +$989 ﹤0.01% 883

Other funds holding CELL

Concord Wealth Partners's CELL Position: Q2 2022 in Review

Concord Wealth Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 26 shares.

Concord Wealth Partners first reported a position in CELL in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Concord Wealth Partners reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 26 PhenomeX Inc. Common Stock shares in Q2 2022.
  • Concord Wealth Partners first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Concord Wealth Partners's PhenomeX Inc. Common Stock position peaked at $1K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.